# Production Knowledge Base Roadmap

## Current Status Assessment
- ✅ **Architecture**: Solid 4-tier structure
- ✅ **ORB Engine**: Working intelligent routing
- ✅ **Sample Data**: 3 medications with basic profiles
- ❌ **Production Depth**: Need 100+ medications with complete clinical profiles
- ❌ **Complex Algorithms**: Need real nomograms and titration protocols
- ❌ **Evidence Integration**: Need dynamic guideline linking

## Phase 2A: Complete Vertical Slices (4-6 weeks)

### Priority 1: High-Impact Clinical Scenarios
1. **Heparin Infusion (Obesity-Adjusted)**
   - Complex weight calculations
   - aPTT nomogram integration
   - HIT surveillance protocols
   
2. **Vancomycin (Dialysis Patients)**
   - Renal function assessment
   - Trough level targeting
   - Nephrotoxicity monitoring
   
3. **Insulin (DKA Protocol)**
   - Complex titration algorithms
   - Multi-parameter monitoring
   - Safety guardrails

4. **Warfarin (Pharmacogenomic)**
   - CYP2C9/VKORC1 integration
   - INR nomogram protocols
   - Drug interaction screening

5. **Acetaminophen (Pediatric)**
   - Age/weight-based dosing
   - Hepatotoxicity prevention
   - Overdose protocols

### Deliverables per Vertical Slice
- **MKC Entry**: Complete medication profile
- **ORB Rules**: 2-3 routing rules with conditions
- **Clinical Recipe**: Full algorithm with variants
- **Context Recipe**: Targeted data requirements
- **Evidence Links**: Guideline references
- **Monitoring Protocol**: Complete surveillance plan
- **Formulary Data**: Cost and availability info

## Phase 2B: Knowledge Base Scaling (8-12 weeks)

### Tier 1: High-Alert Medications (25 medications)
- Insulin (all formulations)
- Heparin/LMWH family
- Warfarin/DOACs
- Chemotherapy agents
- Vasopressors/Inotropes
- Opioids (high-dose)

### Tier 2: Common Inpatient Medications (50 medications)
- Antibiotics (vancomycin, piperacillin-tazobactam, ceftriaxone)
- Cardiovascular (metoprolol, lisinopril, amlodipine)
- Endocrine (metformin, glipizide, levothyroxine)
- Respiratory (albuterol, prednisone, azithromycin)
- Pain management (morphine, fentanyl, acetaminophen)

### Tier 3: Specialty Medications (25+ medications)
- Immunosuppressants
- Anticonvulsants
- Psychiatric medications
- Oncology supportive care

## Phase 2C: Advanced Features (6-8 weeks)

### Dynamic Evidence Integration
- Real-time FDA alert integration
- Guideline version management
- Clinical trial data feeds
- Institutional protocol updates

### Complex Clinical Logic
- Multi-drug interaction analysis
- Allergy cross-reactivity
- Renal/hepatic dose adjustment algorithms
- Pediatric/geriatric considerations

### Quality Assurance
- Clinical pharmacist review workflows
- Evidence validation processes
- Knowledge base versioning
- Audit trail requirements

## Implementation Strategy

### Team Structure
- **Clinical Informatics**: ORB rules and clinical logic
- **Pharmacy**: MKC and formulary data
- **Platform Engineering**: Context recipes and data integration
- **Clinical Excellence**: Evidence repository and guidelines
- **Quality & Safety**: Monitoring protocols and alerts

### Development Approach
1. **Vertical Slice Development**: All teams work on same use case
2. **Weekly Integration**: End-to-end testing of complete pathways
3. **Clinical Review**: Pharmacist validation of each vertical slice
4. **Performance Testing**: Sub-second response time validation
5. **Safety Validation**: Comprehensive error condition testing

### Success Metrics
- **Coverage**: 100+ medications with complete profiles
- **Accuracy**: >99% clinical algorithm correctness
- **Performance**: <700ms end-to-end response time
- **Safety**: Zero critical medication errors in testing
- **Usability**: Clinical user acceptance >90%

## Risk Mitigation

### Clinical Risk
- **Mitigation**: Mandatory clinical pharmacist review
- **Validation**: Comparison with existing clinical protocols
- **Testing**: Comprehensive safety scenario testing

### Technical Risk
- **Mitigation**: Incremental vertical slice development
- **Validation**: Continuous integration testing
- **Monitoring**: Real-time performance metrics

### Operational Risk
- **Mitigation**: Phased rollout with pilot units
- **Training**: Comprehensive clinical user training
- **Support**: 24/7 clinical decision support team

## Timeline Summary
- **Phase 2A** (Vertical Slices): 4-6 weeks
- **Phase 2B** (Knowledge Scaling): 8-12 weeks  
- **Phase 2C** (Advanced Features): 6-8 weeks
- **Total**: 18-26 weeks to production-ready knowledge base

This approach ensures we build a clinically sound, evidence-based, and production-ready clinical decision support system.
